Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT02531932
Title Comparison of Single-Agent Carboplatin vs the Combination of Carboplatin and Everolimus for the Treatment of Advanced Triple-Negative Breast Cancer
Recruitment Recruiting
Gender female
Phase Phase II
Variant Requirements No
Sponsors Amy Tiersten
Indications

triple-receptor negative breast cancer

Therapies

Carboplatin

Everolimus

Age Groups: adult
Covered Countries USA

Facility Status City State Zip Country Details
Mount Sinai Downtown Recruiting New York New York 10011 United States Details
Mount Sinai West Recruiting New York New York 10019 United States Details
Icahn School of Medicine at Mount Sinai Recruiting New York New York 10029 United States Details
*Shaded cells indicate that there was no data available from clincialtrials.gov for the field